ESC 365 - Doctor Odayme Quesada

Speaker illustration

Doctor Odayme Quesada

The Christ Hospital Health Network, Cincinnati (United States of America)

Member of:

European Society of Cardiology

Dr. Odayme Quesada, MD, MHS, FACC, FAHA, FESC is a distinguished clinician-scientist, board-certified cardiologist, and Assistant Professor at the University of Cincinnati serving as the Medical Director of the Women’s Heart Center at The Christ Hospital Heart and Vascular Institute and holding the Ginger Warner Endowed Chair in Women’s Cardiovascular Health. Dr. Quesada's earned both her MD and MHS degrees from Yale University School of Medicine, followed by an internal medicine residency at the University of California San Francisco (UCSF). Her advanced training in cardiovascular medicine includes both a clinical cardiovascular fellowship and an NIH T32 cardiovascular research fellowship at the Cedars-Sinai Smidt Heart Institute. In 2020, Dr. Quesada was recruited to establish and lead The Women’s Heart Center and the Coronary Microvascular and Vasomotor Dysfunction (CMVD) program, a testament to her vision and leadership in the field. She continues to drive advancements in women’s

Presentations Articles

Patients with Angina with Non-Obstructive Coronary Arteries (ANOCA) and migraine have higher rates of epicardial spasm

Event: ESC Congress 2025

Topic: Neurologic Disorders and Heart Disease

Session: Cardiovascular comorbidities: focus on neurologic disease and HIV

Empagliflozin significantly reduces circulating markers of endothelial dysfunction in Ischemia with Non-Obstructive Coronary Arteries (INOCA) and coronary microvascular dysfunction: a pilot trial

Event: ESC Congress 2025

Topic: Cardiovascular Disease in Women

Session: Cardiovascular disease in women around the world

Empagliflozin significantly reduces the capacity of sera to induce endothelial dysfunction in Ischemia Non-Obstructive Coronary Arteries (INOCA): EMbArk phase II pilot trial

Event: ESC Congress 2025

Topic: Cardiovascular Disease in Women

Session: Women's cardiovascular disease and pregnancy

Evaluation of coronary microvascular dysfunction and vasospasm in patients with angina and non-obstructive coronary artery disease

Event: ESC Congress 2024

Topic: Cardiovascular Disease in Women

Session: Cardiovascular disease in women (5)

Differences in clinical characteristics, angina, and quality of life among patients with microvascular vs vasospastic angina and no obstructive coronary artery disease (ANOCA)

Event: ESC Congress 2024

Topic: Cardiovascular Disease in Women

Session: Cardiovascular disease in women (4)

Using anginal symptoms to predict underlying etiology in patients with angina and no obstructive coronary disease (ANOCA)

Event: ESC Congress 2024

Topic: Cardiovascular Disease in Women

Session: Cardiovascular disease in women (2)

Worse ischemic symptoms and cardiac function in women with suspected ischemia with no obstructive coronary artery disease and adverse pregnancy outcomes history

Event: ESC Congress 2024

Topic: Pregnancy and Cardiovascular Disease

Session: Pregnancy and cardiovascular disease

Sex-Differences in Long-term Mortality in Patients with ST-Segment elevation myocardial infarction with and without obstructive coronary arteries

Event: ESC Congress 2023

Topic: Noninvasive Diagnostic Methods

Session: Invasive diagnostic tools in coronary artery disease

Diagnosis of coronary microvascular dysfunction using magnetocardiography

Event: ESC Congress 2023

Topic: Noninvasive Diagnostic Methods

Session: Diagnostic and imaging methods in coronary artery disease

Magnetocardiography as a noninvasive diagnostic strategy for suspected coronary microvascular dysfunction

Event: ESC Congress 2022

Topic: Noninvasive Diagnostic Methods

Session: Coronary artery disease - Noninvasive diagnostic methods

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources